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Commentary  
 
 
Known effects of levothyroxine and folic acid on serum homocysteine level 
 
 
This refers to Dr. Ziaee et al.’s manuscript published in 
your valuable journal about serum homocysteine level 
entitled “Effects of folic acid plus levothyroxine on serum 
homocysteine level in hypothyroidism”.
 
In this clinical trial 
study the efficacy of concomitant administration of folic acid 
and levothyroxine versus single levothyroxine prescription 
on serum homocysteine level was compared with 
hypothyroid patients. The authors concluded that 
“levothyroxine can decrease serum homocysteine level 
partly; still its combination with folic acid empowers the 
effect. Combination therapy declines serum homocysteine 
level more successfully (1).” 
Thyroid hormone deficiency is associated with increased 
cardiovascular events, which cannot be fully explained by 
the atherogenic changes in lipid profile observed in these 
patients. Increased homocysteine serum level can help to 
explain this increased risk in hypothyroidism patients 
because homocysteine serum level is an important and 
independent risk factor for cardiovascular disease. 
Homocysteine is an amino acid which is derived from 
methionin during its metabolism. Disturbance of methionin 
metabolism in hypothyroidism has been suggested as the 
reason of serum homocysteine level rising. Increasing the 
rate of homocysteine catabolism and diminution of its renal 
excretion was also reported in patients with hypothyroidism 
(1, 2). 
The association between serum homocysteine level and 
ischemic heart disease was shown in a cohort study (3). 
Decrease in serum homocysteine level is expected to 
decrease the mortality rate of ischemic heart disease about 
15% (3, 4).  
Hypothyroidism decreases the hepatic levels of enzymes 
involved in the re-methylation pathway of homocysteine; 
Therefore, an increased serum homocysteine level is 
observed in hypothyroid patients even though serum 
homocysteine is known as a considerable risk factor for 
cardiovascular system, It is seen that hypothyroidism 
treatment by levothyroxin will control the cardiovascular 
risks (2). 
A dosage of 1 mg/d has been shown in a meta-analysis to 
produce the maximum homocysteine reduction. There is a 
dose-response relationship between serum homocysteine 
level and prescribed folic acid dose with no further reduction 
with a higher dosage (5mg/day) (4). This maximum 
reduction is about 25% (about 3 mol/L) (4, 5). The patients 
with higher initial serum homocysteine level are more 
sensitive in response to prescribed daily folic acid (4, 5).   
It seems that using folic acid in conjunction with 
levothyroxine can decrrease the potential harmful effects of 
homocysteine on cardiovascular system (1, 6). Based on our 
clinical experience, there is a clear effect of prescription of 
folic acid 1 mg/day accompanied with levothyroxine on 
serum homocysteine reduction.  
We fully support the valuable advice of the author, but it 
should also be noted that high homocysteine serum level in 
hypothyroid patient is secondary to their underlying 
pathology (2-4). Therefore, prescription of folic acid after 
the normalization of thyroid hormones and confirmation of 
high homocysteine serum level will be a logical advice. We 
suggest in the hypothyroid patients with high serum 
homocysteine level a prescription of 1 mg daily folic acid 
postponded up to 6 weeks after the patients become 
euthyroid.  
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